Abstract
Background and Aim
The purpose of this study was to estimate the sex- and age-specific incidence rates of inflammatory bowel diseases (IBD) in Taiwan. Site-specific cancer occurred in patients with IBD would be reported, too.
Methods
A retrospective study by analyzing the data from the National Health Insurance Research Database of Taiwan.
Results
Between 2000 and 2010, the overall incidence rate of Crohn’s disease (CD) and ulcerative colitis (UC) was 0.208 and 0.838 per 100,000 person-years. For male, the incidence rate of CD was 0.195 (95 % CI 0.113–0.276) per 100,000 persons in 2000 and increased to 0.318 (95 % CI 0.216–0.421) per 100,000 persons in 2010. For female, the incidence rate of CD was 0.092 (95 % CI 0.035–0.149) per 100,000 persons in 2000 and increased to 0.210 (95 % CI 0.128–0.293) per 100,000 persons in 2010. For male, the incidence rate of UC was 0.690 (95 % CI 0.537–0.843) per 100,000 persons in 2000 and increased to 1.351 (95 % CI, 1.140–1.562) per 100,000 persons in 2010. For female, the incidence rate of UC was 0.386 (95 % CI 0.269–0.503) per 100,000 persons in 2000 and increased to 0.858 (95 % CI 0.691–1.024) per 100,000 persons in 2010. Among the CD patients, 0.19 % had colorectal cancers (1/519). Among the UC patients, 0.24 % had colorectal cancers (5/2098).
Conclusions
This nationwide population-based longitudinal epidemiological study of IBD in Taiwan provides data for future global comparisons.
Similar content being viewed by others
References
Abraham C, Cho Judy H. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.
Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time based on systematic review. Gastroenterology. 2012;142:46–54.
Economou M, Pappas G. New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–720.
Thia KT, Loftus E, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–3182.
Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280.
Kuo CFSL, Yu KH, Chou IJ, et al. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2011;40:373–378.
Chiang C-J, Chen YC, Chen C-J, You S-L, Lai M-S, Taiwan cancer registry task force. Cancer Trends in Taiwan. Jpn J Clin Oncol. 2010;40:897–904.
Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165.
Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.
Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Alim Pharmacol Ther. 2014;39:459–477.
Joannie R, Ruel CH, Charpentier C, Gower-Rousseau C, Colombel J-F. IBD in the elderly. Inflamm Bowel Dis Monit. 2013;14:1–11.
Ananthakrishnan ANBD. Treatment of ulcerative colitis in the elderly. Dig Dis. 2009;27:327–334.
Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions. Am J Gastroenterol. 2011;106:1889–1897.
Herrinton LJLL, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.
Pedersen NDD, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480–1487.
Jess TRC, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.
Ooi CJ, Fock KM, Makharia GK. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010;25:453–468.
Katsanos KH, Pedersen N, Shuhaibar M, et al. Cancer in inflammatory bowel disease 15 years aft er diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis. 2011;5:430–442.
Kim BJYS, Kim JS, Jeen YT, et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: a KASID study. J Gastroenterol Hepatol. 2009;24:667–671.
Wei S-C, Shieh MJ, Chang MC, Chang YT, Wang C-Y, Wong J-M. Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc. 2012;75:151–155.
Rutter MD, Saunder BP, Wilkinson KH, et al. Thirty year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–1038.
Jess T, Horvath-Puho E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a danish population-based cohort study. Am J Gastroenterol. 2013;108:1869–1876.
Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390–399.
Jess T, Simensen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381.
Kappelman MD, Farkas D, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:265–273.
Zheng JJZX, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn’s disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 2010;11:161–166.
Asakura KNY, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.
Yao TMT, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.
Yang SKYS, Kim JH, Park JY, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.
Sood AMV, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab. North India Gut. 2003;52:1587–1590.
Lee YMFK, See SJ, Ng TM, Khor C, Teo EK. Racial differences in the prevalence of ulcerative colitis and Crohn’s disease in Singapore. J Gastroenterol Hepatol. 2000;15:622–625.
Acknowledgments
CJ Kuo, KH Yu, CT Chiu, MY Su, CM Hsu, CF Kuo, and HW Wang developed the study concept and design and provided the critical revision of the manuscript for important intellectual content. LC See, MJ Chiou, and JR Liu collected and interpreted the data. All authors approved the final version of the manuscript.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuo, CJ., Yu, KH., See, LC. et al. The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Dig Dis Sci 60, 2454–2462 (2015). https://doi.org/10.1007/s10620-015-3630-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-015-3630-z